Anthera Pharmaceuticals, Inc. (OTCMKTS:ANTH – Get Free Report)’s stock price crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.00 and traded as high as $0.00. Anthera Pharmaceuticals shares last traded at $0.00, with a volume of 0 shares traded.
Anthera Pharmaceuticals Stock Performance
About Anthera Pharmaceuticals
Anthera Pharmaceuticals, Inc, a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated autoimmune diseases, including immunoglobulin A nephropathy or IgA nephropathy.
Recommended Stories
- Five stocks we like better than Anthera Pharmaceuticals
- Russell 2000 Index, How Investors Use it For Profitable Trading
- 2 Ways to Trade Qualcomm Ahead of November’s Earnings
- Investing in Construction Stocks
- Lululemon: 2 Signs the Bottom Is In, and 1 Sign It Isn’t
- What Does a Stock Split Mean?
- Got 1K to Invest? These 3 Stocks Are Still Attractive Buys
Receive News & Ratings for Anthera Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthera Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
